InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,904.40
(
0.29%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.44
(
-1.24%
)
Bitcoin
56,215.96
(
0.66%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopearl

Send PM Follow Ignore
Followers 6
Posts 760
Boards Moderated 0
Alias Born 07/18/2006

biopearl

Re: arnoos post# 18601

Monday, 03/30/2009 10:17:55 AM

Monday, March 30, 2009 10:17:55 AM

Post# of 19309
I am pleased to see I was incorrect in my assumption the the sale of Ovation to Lundbeck would focus only on the neurology product line and deemphasize Atryn. This appears not to be the case and I am reassured by today's press release. bp
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up